$FEED

ENVUE MEDICAL INC NEW

Surgical appliances and supplies · Pink Limited

0.665 +40.00% as of 9/22/2026, 1:55:23 AM · delayed

Sentiment

BULLISH BEARISH

No open positions yet.

No threads yet for $FEED. Be the first to post.

Official links

Filings

8-K Wed Oct 14 2026 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov View
EFFECT Thu Sep 03 2026 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov
8-K Mon Aug 31 2026 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov View
10-Q Mon Aug 17 2026 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov View
8-K Fri Aug 14 2026 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov View
NT 10-Q Fri Aug 14 2026 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov
8-K Wed Aug 12 2026 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov View
S-3 Mon Aug 10 2026 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov

All filings

Timeline

filing 10/13/2026 8-K filed
revenue 9/21/2026 Revenue reported: $2.6M, year ended Dec 31, 2025
revenue 9/21/2026 Revenue reported: $2.6M, year ended Dec 31, 2024
revenue 9/21/2026 Revenue reported: $2.3M, year ended Dec 31, 2023
revenue 9/21/2026 Revenue reported: $752K, year ended Dec 31, 2022
revenue 9/21/2026 Revenue reported: $1.7M, year ended Dec 31, 2021
revenue 9/21/2026 Revenue reported: $623K, year ended Dec 31, 2020
revenue 9/21/2026 Revenue reported: $530K, year ended Dec 31, 2019
revenue 9/21/2026 Revenue reported: $318K, year ended Dec 31, 2018
revenue 9/21/2026 Revenue reported: $239K, quarter ended Jun 30, 2026

Company reliability

–

No resolved statements yet.

Revenue

Quarterly

Jun 2026 $239K
Mar 2026 $653K
Dec 2025 $312K derived
Sep 2025 $722K

Annual

FY 2025 $2.6M
FY 2024 $2.6M
FY 2023 $2.3M

Source: SEC XBRL

CEO compensation

$602K (FY 2025) · 0.2x revenue

Doron Besser (current CEO) - $602K total disclosed since 2025

Doron Besser

10-K

Provisional - extracted from filings, not verified.

FY 2024 $424K extracted
FY 2023 $542K extracted

Notes & debt

Provisional - extracted from filings, not verified.

NEARING / AGED
$1K due Dec 31, 2026 8% 10-Q · 2026-08-17

Quote

Convertible Debenture On February 13, 2025, the Company entered into a Securities Purchase Agreement with Alpha, pursuant to which the Company issued a senior convertible debenture (the “Debenture”) with an initial principal amount of $ 500 , subsequently amended and restated on March 26, 2025 to increase the principal amount to $ 1,300 .
OTHER ISSUANCES
— — 8-K · 2026-10-14

Quote

Item 9.01 Financial Statements and Exhibits. (d) Exhibits 3.1 Certificate of Amendment to the Company’s Certificate of Designations of Preferences, Rights and Limitations of Series X Non-Voting Convertible Preferred Stock of ENvue Medical, Inc. 10.1 Secured Promissory Note and Security Agreement, dated October 8, 2026, by and between ENvue Medical, Inc. and Alpha Capital Anstalt. 10.2 Amendment Agreement, dated October 8, 2026, by and between ENvue Medical, Inc. and the holders party thereto. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
$777 — 10-Q · 2026-08-17

Quote

Cash provided by financing activities during the six months ended June 30, 2025, was approximately $7,900, primarily resulting from net proceeds of $8,215 from the sale of Series G Preferred Stock, $1,300 in proceeds from issuance of notes payable to a related party, $360 from the issuance of a short-term loan payable, and $102 in proceeds from exercise of options, partially offset by payments of $1,300 on a related party note payable and $777 on a short-term loan to a related party.
No notes match this filter.

Top predictors

No resolved predictions on $FEED yet.

Upcoming resolutions

Nothing awaiting resolution.